小梁切除术与Ahmed青光眼阀植入术治疗Sturge-Weber综合征继发性青光眼的疗效比较
该回顾性研究纳入40眼Sturge-Weber综合征继发性青光眼,比较Ahmed青光眼阀(AGV)与小梁切除术联合丝裂霉素C的疗效。两组术后眼压均显著下降,24个月完全成功率分别为80%和70%,差异无统计学意义。两种术式均安全有效,但需警惕脉络膜脱离等严重并发症,建议围手术期维持眼压稳定。
要点
- AGV与小梁切除术均能显著降低SWS继发性青光眼眼压。
- 24个月完全成功率AGV组80%、小梁切除组70%,差异无统计学意义。
- SWS手术需警惕脉络膜脱离,建议围手术期维持眼压稳定。
核心结论
- AGV植入与小梁切除术联合丝裂霉素C在控制SWS继发性青光眼方面均安全有效。
- SWS患者手术需预期脉络膜脱离等严重并发症可能,建议术中及术后维持眼压稳定。
研究设计与样本
- 回顾性病历回顾研究,纳入40眼SWS继发性青光眼,分为AGV组(N=20)和小梁切除术联合丝裂霉素C组(N=20)。
- 评估术前及术后人口学数据、眼压、视力及抗青光眼药物数量。
- 手术成功定义为眼压≤21 mm Hg,伴或不伴局部抗青光眼药物;完全成功为不使用抗青光眼药物达到该眼压。
主要发现
- AGV组平均随访23.15±2.36个月,小梁切除组22.95±2.87个月(p=0.811)。
- AGV组眼压从基线34.50±4.65 mm Hg降至末次随访15.20±3.31 mm Hg(p=0.000)。
- 小梁切除组眼压从32.10±5.86 mm Hg降至16.10±3.02 mm Hg(p=0.000)。
- 24个月完全成功Kaplan-Meier生存率AGV组80%、小梁切除组70%,组间差异无统计学意义(p=0.442)。
关键数值与推荐
- 手术成功:眼压≤21 mm Hg,伴或不伴局部抗青光眼药物。
- 完全成功:不使用抗青光眼药物达到眼压≤21 mm Hg。
临床怎么用
- SWS继发性青光眼可选择AGV植入或小梁切除术联合丝裂霉素C,两者疗效相当。
- 围手术期应维持眼压稳定,以降低脉络膜脱离等严重并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To compare the surgical outcomes of trabeculectomy versus Ahmed glaucoma valve (AGV) implantation in the surgical management of glaucoma in patients with Sturge-Weber syndrome (SWS). METHODS: A retrospective chart review was performed on 40 eyes of secondary glaucoma in patients with SWS separated into two groups: AGV (N=20) and trabeculectomy with mitomycin C (N=20). Demographic data, intraocular pressure (IOP), visual acuity and the number anti-glaucoma medications (AGM) needed were evaluated prior to and following surgery. Surgical success was defined as an IOP of ≤21 mm Hg, with or without the use of topical AGM. Complete success was achieved when IOP values were obtained without AGM. RESULTS: Mean follow-up duration was 23.15±2.36 months and 22.95±2.87 months in the AGV and trabeculectomy groups, respectively (p=0.811). Both the AGV (34.50±4.65 mm Hg at baseline to 15.20±3.31 mm Hg at last visit) and trabeculectomy (32.10±5.86 mm Hg to 16.10±3.02 mm Hg) groups achieved a statistically significant fall in IOP following surgery (p=0.000). Kaplan-Meier survival of complete success after 24 months was 80% and 70% after AGV implant and trabeculectomy, respectively, but the difference between two groups was not statistically significant (p=0.442). CONCLUSIONS: Both AGV implant and trabeculectomy appear to be safe and efficacious in controlling glaucoma secondary to SWS, although the potential for serious complications such as choroidal detachment must be anticipated when planning surgeries in patient with SWS, and the authors recommend the maintenance of a stable IOP during and following the surgery to avoid such complications.
引用
- Sarker BK, Malek MA, Mannaf SMA, et al. Outcome of trabeculectomy versus Ahmed glaucoma valve implantation in the surgical management of glaucoma in patients with Sturge-Weber syndrome. Br J Ophthalmol. 2020. PMID: 32912851. doi:10.1136/bjophthalmol-2020-317098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。